212 related articles for article (PubMed ID: 10456621)
61. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
Palareti G; Legnani C
Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
[TBL] [Abstract][Full Text] [Related]
62. Effects on thrombin generation of single injections of Hirulog in patients with calf vein thrombosis.
Ginsberg JS; Nurmohamed MT; Gent M; MacKinnon B; Stevens P; Weitz J; Maraganore J; Hirsh J
Thromb Haemost; 1994 Oct; 72(4):523-5. PubMed ID: 7878625
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2.
Takahashi H; Wada K; Satoh N; Takakuwa E; Furuta R; Yoshino N; Shibata A
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):435-9. PubMed ID: 8329570
[TBL] [Abstract][Full Text] [Related]
64. Problems of anticoagulation with warfarin in hyperthyroidism.
Kellett HA; Sawers JS; Boulton FE; Cholerton S; Park BK; Toft AD
Q J Med; 1986 Jan; 58(225):43-51. PubMed ID: 3704105
[TBL] [Abstract][Full Text] [Related]
65. Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase.
Weinstock DM; Chang P; Aronson DL; Kessler CM
Am J Hematol; 1998 Mar; 57(3):193-9. PubMed ID: 9495368
[TBL] [Abstract][Full Text] [Related]
66. Anticoagulant therapy for deep vein thrombosis: its proper application.
Rohrer MJ; Anderson FA
Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021
[No Abstract] [Full Text] [Related]
67. Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection.
Hursting MJ; Slaughter TF; Stead AG; Szewczyk KM; Witt DJ; Greenberg CS
Arch Pathol Lab Med; 1998 Jan; 122(1):31-6. PubMed ID: 9448013
[TBL] [Abstract][Full Text] [Related]
68. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases].
Kawai Y; Shiomi T; Ono H; Katagiri H; Uchida R; Sugisaki N; Watanabe K
Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.
Carter BL; Taylor JW; Becker A
Clin Pharm; 1987 Jan; 6(1):37-45. PubMed ID: 3816105
[TBL] [Abstract][Full Text] [Related]
70. A randomized trial of initial warfarin dosing based on simple clinical criteria.
Shine D; Patel J; Kumar J; Malik A; Jaeger J; Maida M; Ord L; Burrows G
Thromb Haemost; 2003 Feb; 89(2):297-304. PubMed ID: 12574810
[TBL] [Abstract][Full Text] [Related]
71. Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway.
Schoenenberger RA; Pearson SD; Goldhaber SZ; Lee TH
Am J Med; 1996 Mar; 100(3):278-82. PubMed ID: 8629672
[TBL] [Abstract][Full Text] [Related]
72. Monitoring "mini-intensity" anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1+2 levels.
Millenson MM; Bauer KA; Kistler JP; Barzegar S; Tulin L; Rosenberg RD
Blood; 1992 Apr; 79(8):2034-8. PubMed ID: 1562730
[TBL] [Abstract][Full Text] [Related]
73. Effects of fixed low-dose warfarin on hemostatic factors in continuous ambulatory peritoneal dialysis patients.
Kim SB; Lee SK; Park JS; Chi HS; Hong CD; Yang WS
Am J Kidney Dis; 2001 Feb; 37(2):343-7. PubMed ID: 11157376
[TBL] [Abstract][Full Text] [Related]
74. Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension.
Jansa P; Hrachovinova I; Ambroz D; Maresova J; Polacek P; Simkova I; Linhart A; Aschermann M
Bratisl Lek Listy; 2010; 111(11):595-8. PubMed ID: 21384745
[TBL] [Abstract][Full Text] [Related]
75. Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation.
Astermark J; Björgell O; Lindén E; Lethagen S; Nilsson P; Berntorp E
J Intern Med; 1998 Jul; 244(1):79-82. PubMed ID: 9698028
[TBL] [Abstract][Full Text] [Related]
76. International Normalized Ratio (INR), coagulation factor activities and calibrated automated thrombin generation - influence of 24 h storage at ambient temperature.
Christensen TD; Jensen C; Larsen TB; Maegaard M; Christiansen K; Sørensen B
Int J Lab Hematol; 2010 Apr; 32(2):206-14. PubMed ID: 19486195
[TBL] [Abstract][Full Text] [Related]
77. Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal.
Poli D; Antonucci E; Ciuti G; Abbate R; Prisco D
J Thromb Haemost; 2008 Apr; 6(4):708-10. PubMed ID: 18194414
[No Abstract] [Full Text] [Related]
78. Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin.
Martini A; Jähnchen E
J Pharmacol Exp Ther; 1977 Jun; 201(3):547-53. PubMed ID: 864594
[TBL] [Abstract][Full Text] [Related]
79. Review of the initiation of anticoagulant therapy.
Corbett NE; Peterson GM
J Clin Pharm Ther; 1995 Aug; 20(4):221-4. PubMed ID: 8557786
[TBL] [Abstract][Full Text] [Related]
80. Low-dose warfarin decreases coagulability without affecting prothrombin complex activity.
Holm J; Berntorp E; Carlsson R; Erhardt L
J Intern Med; 1993 Sep; 234(3):303-8. PubMed ID: 8354981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
